
\begin{table}[htb]\centering
\caption{Logit Coefficients \\ Dependent variable: Generous PPM}
\begin{tabular}{l*{8}c}

 & (1) & (2) & (3) & (4) & (5) & (6) & (7) & (8)  \\
 & All & All & All & All (clustered SE) & Recent & Recent & Recent & Recent (clustered SE)  \\

                    &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   \\

\hline

       &               &               &               &               &               &               &               &               \\
Trial start year    &       0.068***&       0.068***&       0.067***&       0.069***&       0.102***&       0.102***&       0.102***&       0.104***\\
                    &     (0.003)   &     (0.003)   &     (0.003)   &     (0.004)   &     (0.005)   &     (0.005)   &     (0.005)   &     (0.006)   \\
\shortstack[l]{Phase 2 Clinical\\(includes Phase 2/Phase 3 trials)} &       0.279***&               &       0.268***&       0.275** &       0.328***&               &       0.314***&       0.322***\\
                    &     (0.033)   &               &     (0.033)   &     (0.089)   &     (0.036)   &               &     (0.036)   &     (0.090)   \\
Phase 3 Clinical    &       0.405***&       0.403***&       0.383***&       0.397*  &       0.440***&       0.437***&       0.417***&       0.430*  \\
                    &     (0.047)   &     (0.047)   &     (0.047)   &     (0.182)   &     (0.051)   &     (0.051)   &     (0.051)   &     (0.182)   \\
Trial site in US=1  &       0.139***&       0.136***&       0.711***&       0.727***&       0.149***&       0.147***&       0.761***&       0.776***\\
                    &     (0.031)   &     (0.032)   &     (0.066)   &     (0.114)   &     (0.033)   &     (0.033)   &     (0.069)   &     (0.127)   \\
Drug indication for neoplasm&       2.745***&       2.739***  &       3.101***&       3.120***&         2.794***&       2.787*** &       3.170***&       3.188*** \\
                    &     (0.038)   &     (0.039)   &     (0.055)   &     (0.119)   &      (0.040)   &     (0.041)   &     (0.058)   &     (0.124)   \\
Received NIH funding&      -0.151*  &      -0.151*  &      -0.104   &      -0.104***&      -0.192** &      -0.193** &      -0.136*  &      -0.134***\\
                    &     (0.063)   &     (0.063)   &     (0.063)   &     (0.015)   &     (0.070)   &     (0.070)   &     (0.069)   &     (0.019)   \\
Biomarker type: genomic&       4.713***&       4.713***&       4.728***&       4.727***&       4.735***&       4.734***&       4.754***&       4.757***\\
                    &     (0.068)   &     (0.068)   &     (0.068)   &     (0.279)   &     (0.075)   &     (0.075)   &     (0.075)   &     (0.317)   \\
Phase 2 only        &               &       0.285***&               &               &               &       0.335***&               &               \\
                    &               &     (0.034)   &               &               &               &     (0.036)   &               &               \\
Phase 2/3 Clinical  &               &       0.143   &               &               &               &       0.162   &               &               \\
                    &               &     (0.105)   &               &               &               &     (0.111)   &               &               \\
\shortstack[l]{Trial site in US=1\\$\times$ Drug indication for neoplasm=1}&               &               &      -0.732***&      -0.745***&               &               &      -0.789***&      -0.801***\\
                    &               &               &     (0.074)   &     (0.113)   &               &               &     (0.078)   &     (0.129)   \\
Constant            &    -143.869***&    -143.910***&    -143.462***&    -145.976***&    -212.276***&    -212.390***&    -213.810***&    -217.810***\\
                    &     (7.030)   &     (7.030)   &     (7.021)   &     (7.894)   &    (10.107)   &    (10.108)   &    (10.104)   &    (12.564)   \\
N                   &      113410   &      113410   &      113410   &      106626   &       96254   &       96254   &       96254   &       90650   \\
* p$<$0.05, ** p$<$0.01, *** p$<$0.001 \\

\end{tabular}
\end{table}

